Buy-Side Mandate: Medical Billing / RCM Platform ($500k - $1.5M EBITDA)

searcher profile

January 14, 2026

by a searcher from Arizona State University - W. P. Carey School of Business in Miami, FL, USA

I am an Independent Sponsor executing a roll-up strategy in the Medical Billing / Revenue Cycle Management (RCM) space. We are looking to acquire a platform asset immediately, with a committed capital structure in place to close quickly. Investment Criteria: Sector: Medical Billing / RCM (Specialty agnostic, but prefer Cardio, Ortho, or Behavioral Health). Financials: $500k – $1.5M EBITDA (Platform); $200k+ (Add-ons). Geography: Nationwide (Remote-first preferred). Model: Recurring revenue, low customer concentration (<15%). Deal Structure: We are modeled for a standard leveraged buyout (Senior Debt + Seller Financing). We are SBA-eligible if the asset requires it. We are comfortable with complex deal structures and can move to LOI within 7-14 days of data room access. For Intermediaries: Buy-side fees are protected. If you have a pocket listing that fits this box, please DM me. We provide feedback on teasers within 24 hours.
3
6
122
Replies
6
commentor profile
Reply by a searcher
from Harvard University in Boston, MA, USA
Thanks ^redacted‌ for the tag. ^redacted‌ happy to pass along your info if I come across active rcm opportunities
commentor profile
Reply by a searcher
from Touro University in Bluffton, South Carolina, United States
Thanks for the tag! I actually own a medical billing company that is remote and while we do meet those criteria, we are not quite yet for sale. I am on a mission to get it a few more doubles. Though we do not have a software platform. We are currently doing the service side with about 30 practices.
commentor profile
+4 more replies.
Join the discussion